Fycompa
| Chemical Name | perampanel |
| Dosage Form | Tablet (oral; 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg); Suspension (oral; 0.5 mg/mL) |
| Drug Class | Non-competitive AMPA glutamate receptor antagonists |
| System | Nervous |
| Company | Eisai |
| Approval Year | 2012 |
Indication
- Indicated for treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older.
- Indicated for adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older.